FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285588314> ?p ?o ?g. }

• W4285588314 abstract "BACKGROUND: To examine long-term-survival of cT4 cN0/1 cM0 non-small-cell lung carcinoma (NSCLC) patients undergoing definitive radiochemotherapy (ccRTx/CTx) in comparison to the trimodality treatment, neoadjuvant radiochemotherapy followed by surgery, at a high volume lung cancer center.All consecutive patients with histopathologically confirmed NSCLC (cT4 cN0/1 cM0) with a curative-intent-to-treat ccRTx/CTx were included between 01.01.2001 and 01.07.2019. Mediastinal involvement was excluded by systematic EBUS-TBNA or mediastinoscopy. Following updated T4-stage-defining-criteria initial staging was reassessed by an expert-radiologist according to UICC-guidelines [8th edition]. Outcomes were compared with previously reported results from patients of the same institution with identical inclusion criteria, who had been treated with neoadjuvant radiochemotherapy and resection. Factors for treatment selection were documented. Endpoints were overall-survival (OS), progression-free-survival (PFS), and cumulative incidences of isolated loco-regional failures, distant metastases, secondary tumors as well as non-cancer deaths within the first year.Altogether 46 consecutive patients with histopathologically confirmed NSCLC cT4 cN0/1 cM0 [cN0 in 34 and cN1 in 12 cases] underwent ccRTx/CTx after induction chemotherapy (iCTx). Median follow-up was 133 months. OS-rates at 3-, 5-, and 7-years were 74.9%, 57.4%, and 57.4%, respectively. Absolute OS-rate of ccRTx/CTx at 5 years were within 10% of the trimodality treatment reference group (Log-Rank p = 0.184). The cumulative incidence of loco-regional relapse was higher after iCTx + ccRT/CTx (15.2% vs. 0% at 3 years, p = 0.0012, Gray's test) while non-cancer deaths in the first year were lower than in the trimodality reference group (0% vs 9.1%, p = 0.0360, Gray's test). None of the multiple recorded prognostic parameters were significantly associated with survival after iCTx + ccRT/CTx: Propensity score weighting for adjustment of prognostic factors between iCTx + ccRT/CTx and trimodality treatment did not change the results of the comparisons.Patients with cT4 N0/1 M0 NSCLC have comparable OS with ccRTx/CTx and trimodality treatment. Loco-regional relapses were higher and non-cancer related deaths lower with ccRTx/CTx. Definitive radiochemotherapy is an adequate alternative for patients with an increased risk of surgery-related morbidity." @default.
• W4285588314 created "2022-07-16" @default.
• W4285588314 creator A5000688820 @default.
• W4285588314 creator A5034451063 @default.
• W4285588314 creator A5036507802 @default.
• W4285588314 creator A5037650981 @default.
• W4285588314 creator A5040777787 @default.
• W4285588314 creator A5043479866 @default.
• W4285588314 creator A5044483876 @default.
• W4285588314 creator A5047006205 @default.
• W4285588314 creator A5071494218 @default.
• W4285588314 creator A5075140523 @default.
• W4285588314 creator A5075896912 @default.
• W4285588314 creator A5082059315 @default.
• W4285588314 creator A5086393240 @default.
• W4285588314 date "2022-07-16" @default.
• W4285588314 modified "2023-09-25" @default.
• W4285588314 title "Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment" @default.
• W4285588314 cites W1551848447 @default.
• W4285588314 cites W1817196311 @default.
• W4285588314 cites W1954745527 @default.
• W4285588314 cites W1986794774 @default.
• W4285588314 cites W1991423338 @default.
• W4285588314 cites W2007743553 @default.
• W4285588314 cites W2013656320 @default.
• W4285588314 cites W2030986498 @default.
• W4285588314 cites W2049531892 @default.
• W4285588314 cites W2057313094 @default.
• W4285588314 cites W2105024669 @default.
• W4285588314 cites W2110490360 @default.
• W4285588314 cites W2116093348 @default.
• W4285588314 cites W2133223019 @default.
• W4285588314 cites W2138960985 @default.
• W4285588314 cites W2144052826 @default.
• W4285588314 cites W2144163456 @default.
• W4285588314 cites W2145728881 @default.
• W4285588314 cites W2156857693 @default.
• W4285588314 cites W2170266180 @default.
• W4285588314 cites W2171729476 @default.
• W4285588314 cites W2228221433 @default.
• W4285588314 cites W2232938618 @default.
• W4285588314 cites W2525001631 @default.
• W4285588314 cites W2584148894 @default.
• W4285588314 cites W2753170381 @default.
• W4285588314 cites W2893824814 @default.
• W4285588314 cites W2903085180 @default.
• W4285588314 cites W2912680256 @default.
• W4285588314 cites W2969265535 @default.
• W4285588314 cites W2969297149 @default.
• W4285588314 cites W2971076236 @default.
• W4285588314 cites W2973782607 @default.
• W4285588314 cites W2995072671 @default.
• W4285588314 cites W3082586784 @default.
• W4285588314 cites W3094020015 @default.
• W4285588314 cites W3108819942 @default.
• W4285588314 cites W3172131160 @default.
• W4285588314 doi "https://doi.org/10.1186/s13014-022-02080-9" @default.
• W4285588314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35842712" @default.
• W4285588314 hasPublicationYear "2022" @default.
• W4285588314 type Work @default.
• W4285588314 citedByCount "0" @default.
• W4285588314 crossrefType "journal-article" @default.
• W4285588314 hasAuthorship W4285588314A5000688820 @default.
• W4285588314 hasAuthorship W4285588314A5034451063 @default.
• W4285588314 hasAuthorship W4285588314A5036507802 @default.
• W4285588314 hasAuthorship W4285588314A5037650981 @default.
• W4285588314 hasAuthorship W4285588314A5040777787 @default.
• W4285588314 hasAuthorship W4285588314A5043479866 @default.
• W4285588314 hasAuthorship W4285588314A5044483876 @default.
• W4285588314 hasAuthorship W4285588314A5047006205 @default.
• W4285588314 hasAuthorship W4285588314A5071494218 @default.
• W4285588314 hasAuthorship W4285588314A5075140523 @default.
• W4285588314 hasAuthorship W4285588314A5075896912 @default.
• W4285588314 hasAuthorship W4285588314A5082059315 @default.
• W4285588314 hasAuthorship W4285588314A5086393240 @default.
• W4285588314 hasBestOaLocation W42855883141 @default.
• W4285588314 hasConcept C121608353 @default.
• W4285588314 hasConcept C126322002 @default.
• W4285588314 hasConcept C141071460 @default.
• W4285588314 hasConcept C143998085 @default.
• W4285588314 hasConcept C146357865 @default.
• W4285588314 hasConcept C151730666 @default.
• W4285588314 hasConcept C2776256026 @default.
• W4285588314 hasConcept C2776694085 @default.
• W4285588314 hasConcept C2778292576 @default.
• W4285588314 hasConcept C2778424827 @default.
• W4285588314 hasConcept C2779961022 @default.
• W4285588314 hasConcept C509974204 @default.
• W4285588314 hasConcept C530470458 @default.
• W4285588314 hasConcept C71924100 @default.
• W4285588314 hasConcept C72563966 @default.
• W4285588314 hasConcept C86803240 @default.
• W4285588314 hasConcept C88879693 @default.
• W4285588314 hasConceptScore W4285588314C121608353 @default.
• W4285588314 hasConceptScore W4285588314C126322002 @default.
• W4285588314 hasConceptScore W4285588314C141071460 @default.
• W4285588314 hasConceptScore W4285588314C143998085 @default.
• W4285588314 hasConceptScore W4285588314C146357865 @default.
• W4285588314 hasConceptScore W4285588314C151730666 @default.
• W4285588314 hasConceptScore W4285588314C2776256026 @default.

• next